Bienaime Jean Jacques
Immunome, Inc. · Director
Bienaime Jean Jacques is listed in public filings as director. This Bienaime Jean Jacques insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Immunome, Inc. (IMNM), Keros Therapeutics, Inc. (KROS), Incyte Corp (INCY), and Ascendis Pharma A/S (ASND). Investors use Bienaime Jean Jacques's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $22k2k shares | BuyMar 9, 2026 | $11.21 | -- | |
| $12k1k shares | BuyApr 15, 2026 | $11.70 | -- | |
| $11k1k shares | BuyMay 15, 2026 | $10.58 | -- | |
| $98k7k shares | BuyAug 16, 2024 | $13.94 | -- | |
| $57k7k shares | BuyMar 24, 2025 | $8.21 | -- | |
| $61k7.8k shares | BuyMar 25, 2025 | $7.78 | -- | |
| $47k5k shares | BuyJun 3, 2025 | $9.38 | -- | |
| $22k1k shares | BuyMar 10, 2026 | $22.12 | -- | |
| $22k1k shares | BuyMar 11, 2026 | $21.55 | -- | |
| $104k5k shares | BuyMay 15, 2026 | $20.70 | -- | |
| $45k200 shares | BuyMay 29, 2026 | $223.76 | -- | |
| $44k200 shares | BuyMay 29, 2026 | $222.30 | -- | |
| $22k100 shares | BuyMay 29, 2026 | $223.50 | -- | |
| $48k200 shares | BuyMay 26, 2026 | $239.37 | -- | |
| $47k200 shares | BuyMay 26, 2026 | $236.24 | -- |